Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

Wei-Qiang Chen; Li Lou; Xiao-Ling Qiang; Cassie Shu Zhu; Jian-Hua Li; Shu-Jin Chen; Brian Xiong; Huan Yang; Ping Wang; Kevin J. Tracey; Hai-Chao Wang

doi:10.1186/s40779-026-00686-8

您当前的位置：

首页 >

文章列表页 >

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

RESEARCH | 更新时间：2026-08-20

- Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
- Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
- Wei-Qiang Chen ，Li Lou ，Xiao-Ling Qiang ，Cassie Shu Zhu ，Jian-Hua Li ，Shu-Jin Chen ，Brian Xiong ，Huan Yang ，Ping Wang ，Kevin J. Tracey ，Hai-Chao Wang
- Military Medical Research 2026年13卷第7期页码：1061-1080
- 作者机构：
  The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA
  Departments of Emergency Medicine and/Or Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/North-well, Hempstead, NY 11549, USA
- 作者简介：
  * Hai-Chao Wang hwang@northwell.edu
- 基金信息：
  NIGMS(R35GM145331);NICCH(R01AT005076)
- DOI： 10.1186/s40779-026-00686-8
  中图分类号：
- 录用：2026-01-30 ，
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
图( 8 ) 表( 0 )
参考文献
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

35

浏览量

66

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

Therapeutic effects of anti-endotoxin antibodies and antibiotics on endotoxemia in patients with severe burns

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation